Abstract
Within an oncology setting, certain chemotherapy drugs, such as cisplatin, may lead to magnesium loss causing nephropathy. Neurological and cardiovascular symptoms caused by hypomagnesaemia are well known. The relationship between serious hypomagnesemia and severe pain is not well documented but nevertheless, when faced with unexplained episodes of pain which do not respond to powerful analgesics, it is important to review blood magnesium levels. We present two cases of opioid-refractory pain attacks. Patients received drugs which have been linked to hypomagnesemia. In both cases, endovenous magnesium replacement led to a drastic improvement in pain management.
This is a preview of subscription content, log in via an institution to check access.
References
Cooper D, Krainik AJ, Lubner S (2007) Washington manual of medical therapeutics, fluid and electrolyte management (32nd edn). Lippincott Williams & Wilkins, Philadelphia, pp 87–91
Schimastscheik HF, Rempis R (2001) Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res 4:283–290
Brogan G, Exton L (2000) The importance of low magnesium in palliative case: two care reports. Palliat Med 1:59–61
Bosch-Barrera J, Urdíroz J, Centeno C (2010) Alucinaciones visuales y dolor inusual en relación a hipomagnesemia en un paciente con cáncer avanzado. An Sist Sanit Navarr 33:319–322
Negri A, Del Valle E (2011) Hypomangesemia/hypokalemia associated with the use of esomeprazole. Current Drug Safety 6(3):204–206
Lajer H, Daugaard G (1999) Cisplatin and hypomagnesemia. Cancer Treat Rev 1:47–58
Wells B, DiPiro J et al. (2006) Pharmacotherapy handbook (6th edn) McGraw-Hill, New York Chapter 76; Electrolyte Homeostasis, pp. 815–816
Cao Y, Liao C et al (2010) Meta-analysis of incidence and risk of hypomagnesemia with cetuximab for advanced cancer. Cancer Chemother 56(6):459–465
Quasdorff M, Mertens J et al (2011) Recurrent hypomagnesemia with proton-pump inhibitor rechallenge. Ann Intern Med 55(6):405–407
Kuipers MT, Thang H, Barntzenius A (2009) Hypomagnesaemia due to use of proton pump inhibitors a review. Neth J Med 67(5):169–172
Bujalska M, Malinowska E et al (2008) Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia. Pharmacology 82(3):180–186
Mert T, Gunes Y, Ozcengiz D et al (2009) Magnesium modifies fentanyl-induced local antinociception and hyperalgesia. Nauyn Schmiedebergs Arch Pharmacol 380:415–420
Celerier E, Rivat C et al (2000) Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiol 92(2):465–472
Chaparro-Gomez LE, Calvache-España A, Arbelez-León L (2010) Coadjuvant analgesics for cancer pain: using the clinical queries PubMed tool. Cirugía y Cirujanos 78(2):185–190
Pickering DE, Gisle GD et al (2011) Oral magnesium treatment in patients with neuropathic pain: a randomized clinical trial. Magnes Res 2:28–35
Whang R et al (1984) Predictors of clinical hypomagnesemia. Hypokalemia, hypophosphatemia, hyponatremia, and hypocalcemia. Arch Iintern Med 144(9):1794–1796
Guijarro de Armas MG, Vega Piñero B et al (2010) Seizures secondary to hypomagnesemia in patients with short bowel syndrome. Nutr Hosp 25(6):1037–1040
Salem M, Kasinski N, Andrei AM, Brussel T, Gold MR, Conn A, Chernow B (1991) Hypomagnesemia is a frequent finding in the emergency department in patients with chest pain. Arch Intern Med 151(11):2185–2190
Conflict of interest
None declared. I have full control of all primary data and I agree to allow the journal to review data if requested.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
López-Saca, J.M., López-Picazo, J.M., Larumbe, A. et al. Hypomagnesemia as a possible explanation behind episodes of severe pain in cancer patients receiving palliative care. Support Care Cancer 21, 649–652 (2013). https://doi.org/10.1007/s00520-012-1669-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-012-1669-3